These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 22015819)
1. COX-derived prostanoid pathways in gastrointestinal cancer development and progression: novel targets for prevention and intervention. Cathcart MC; O'Byrne KJ; Reynolds JV; O'Sullivan J; Pidgeon GP Biochim Biophys Acta; 2012 Jan; 1825(1):49-63. PubMed ID: 22015819 [TBL] [Abstract][Full Text] [Related]
2. Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention. Cathcart MC; Lysaght J; Pidgeon GP Cancer Metastasis Rev; 2011 Dec; 30(3-4):363-85. PubMed ID: 22134655 [TBL] [Abstract][Full Text] [Related]
4. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms. Nasir A; Fernandez PM; Chughtai OR; Kaiser HE In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894 [TBL] [Abstract][Full Text] [Related]
5. COX-2 and colon cancer: potential targets for chemoprevention. Fournier DB; Gordon GB J Cell Biochem Suppl; 2000; 34():97-102. PubMed ID: 10762021 [TBL] [Abstract][Full Text] [Related]
6. Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer. Chell S; Kaidi A; Williams AC; Paraskeva C Biochim Biophys Acta; 2006 Aug; 1766(1):104-19. PubMed ID: 16859832 [TBL] [Abstract][Full Text] [Related]
7. Prostaglandins and the regulation of tumor growth. Bishop-Bailey D; Calatayud S; Warner TD; Hla T; Mitchell JA J Environ Pathol Toxicol Oncol; 2002; 21(2):93-101. PubMed ID: 12086407 [TBL] [Abstract][Full Text] [Related]
8. Prevention of cancer in the upper gastrointestinal tract with COX-inhibition. Still an option? Jiménez P; García A; Santander S; Piazuelo E Curr Pharm Des; 2007; 13(22):2261-73. PubMed ID: 17691999 [TBL] [Abstract][Full Text] [Related]
9. Prostanoids and inflammatory pain. Chen L; Yang G; Grosser T Prostaglandins Other Lipid Mediat; 2013; 104-105():58-66. PubMed ID: 22981510 [TBL] [Abstract][Full Text] [Related]
10. Dual acting anti-inflammatory drugs: a reappraisal. Bertolini A; Ottani A; Sandrini M Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348 [TBL] [Abstract][Full Text] [Related]
11. Prostanoids receptors signaling in different diseases/cancers progression. Yang Y; Tang LQ; Wei W J Recept Signal Transduct Res; 2013; 33(1):14-27. PubMed ID: 23327583 [TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenases, prostanoids, and tumor progression. Wang MT; Honn KV; Nie D Cancer Metastasis Rev; 2007 Dec; 26(3-4):525-34. PubMed ID: 17763971 [TBL] [Abstract][Full Text] [Related]
14. Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention. Kashfi K; Rigas B Biochem Pharmacol; 2005 Oct; 70(7):969-86. PubMed ID: 15949789 [TBL] [Abstract][Full Text] [Related]
15. Selectivity of cyclooxygenase isoform activity and prostanoid production in normal and diseased Han:SPRD-cy rat kidneys. Warford-Woolgar L; Peng CY; Shuhyta J; Wakefield A; Sankaran D; Ogborn M; Aukema HM Am J Physiol Renal Physiol; 2006 Apr; 290(4):F897-904. PubMed ID: 16234308 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors. Ermert L; Dierkes C; Ermert M Clin Cancer Res; 2003 May; 9(5):1604-10. PubMed ID: 12738712 [TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-dependent signaling is causally linked to non-melanoma skin carcinogenesis: pharmacological, genetic, and clinical evidence. Müller-Decker K Cancer Metastasis Rev; 2011 Dec; 30(3-4):343-61. PubMed ID: 22038018 [TBL] [Abstract][Full Text] [Related]
18. A dietary conjugated linoleic acid treatment that slows renal disease progression alters renal cyclooxygenase-2-derived prostanoids in the Han: SPRD-cy rat. Wakefield AP; Ogborn MR; Ibrahim N; Aukema HM J Nutr Biochem; 2012 Aug; 23(8):908-14. PubMed ID: 21940154 [TBL] [Abstract][Full Text] [Related]
19. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers. Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495 [TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]